SCHEDULE: Vanguard Reports 0% Stake in CME Group After Realignment

The Vanguard Group has amended its Schedule 13G filing for CME Group Inc., reporting zero beneficial ownership following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 10 to its Schedule 13G for CME Group Inc. Common Stock.
• The filing indicates that The Vanguard Group now beneficially owns 0.00 shares of CME Group Inc., representing 0% of the class.
• This change stems from an internal realignment at The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538.
• These disaggregated entities will continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these separate subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing. It clarifies The Vanguard Group's beneficial ownership reporting structure for CME Group Inc. but does not indicate a change in investment strategy or performance for either entity.

Positives

• The underlying investment strategies pursued by Vanguard's various entities regarding CME Group Inc. are maintained, despite the change in reporting structure.
• The filing clarifies the beneficial ownership reporting in accordance with SEC guidelines for large investment complexes.

Negatives

• No direct negatives for CME Group Inc. are indicated by this administrative filing.
• The change is primarily an internal reporting adjustment for The Vanguard Group.

Risks

• No specific risks for CME Group Inc. are mentioned in this administrative filing.
• The filing addresses a change in reporting beneficial ownership, not a change in the investment's risk profile.

Future Outlook

No forward-looking statements or guidance for CME Group Inc. are provided in this administrative filing. The filing only addresses a change in beneficial ownership reporting by Vanguard.

Management Comments

• The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
• No one other person's interest in the securities reported herein is more than 5%.
• I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

StockSavvy.ai notes that large institutional investors like The Vanguard Group frequently adjust their reporting structures due to internal reorganizations or regulatory interpretations. This specific filing reflects an administrative change in how Vanguard reports its beneficial ownership, rather than a strategic divestment from CME Group Inc. The underlying investment exposure to CME Group Inc. by Vanguard's various funds and managed accounts is likely maintained, but reported through different entities.

Comparison to Industry Standards

• This filing is an administrative update regarding beneficial ownership reporting, not a performance report. Therefore, direct comparison to industry-standard financial benchmarks or specific company projects is not applicable.
• The disaggregated reporting approach aligns with SEC Release No. 34-39538, a standard practice for large investment complexes to clarify beneficial ownership across various subsidiaries or business divisions.

Stakeholder Impact

• Shareholders (CME Group Inc.): Minimal direct impact as the underlying investment exposure by Vanguard's various funds likely remains, just reported differently. No change in control or strategic direction is implied.
• The Vanguard Group Investors: The change is administrative, ensuring compliance with SEC reporting guidelines for a large, complex organization. Investment strategies remain consistent.

Next Steps

• The Vanguard Group's subsidiaries or business divisions that formerly had beneficial ownership with The Vanguard Group, Inc. will now report their beneficial ownership separately.

Key Dates

Recommendation

This filing is purely administrative, detailing a change in how The Vanguard Group reports its beneficial ownership of CME Group Inc. It does not reflect a change in investment strategy, financial performance, or operational outlook for CME Group Inc. Therefore, a 'hold' recommendation is appropriate as there is no new fundamental information to warrant a change in investment stance based solely on this filing.

Keywords

CME Group Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Ownership, Investment Management, Financial Reporting, Realignment